secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2021-07-02T23:59:59+00:00
Accession:  0001193125-21-207646
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SPAC Social Capital Suvretta III closes $250M IPO and funds trust account
-------------------------------------------------------------------------

- IPO of 25M Class A shares at $10.00 closed July 2, 2021; gross proceeds $250M.
- Concurrent private sale of 640k Private Placement Shares to sponsor for $6.4M.
- Proceeds placed in trust at JP Morgan/Continental; restricted until business combination or 24-month deadline.
- Marc Semigran appointed to board as chairman of audit, compensation, and nominating committees.
- Company targets biotechnology industry, specifically the organ space subsector.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000119312521207646/0001193125-21-207646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000119312521207646/d123596d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-207646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer